Free and open to everyone

Chronic hepatitis B is a vaccine-preventable and treatable chronic disease of the liver and the leading cause of liver cancer worldwide as a result of infection with the hepatitis B virus (HBV). In the United States, 1 in 12 Asian Americans is living with chronic hepatitis B, but over half of them are not aware they have been infected. Samuel So, MD, will talk about hepatitis B, how it is transmitted, prevention, screening, and treatment. He will also share his work on changing public health policies related to hepatitis B and C and the new CDC recommendations to screen all adults in the United States for hepatitis B.

Samuel So, MD, is the Lui Hac Minh Professor and Professor of Surgery. He is the founder of the multidisciplinary liver cancer program at the Stanford Cancer Center and the founder and executive director of the Asian Liver Center at Stanford University School of Medicine. His current clinical area of specialty is multidisciplinary approach in the treatment of primary liver cancer and management of chronic hepatitis B infection.